ArticleLife (Basel, Switzerland)2024

Evaluation of an Antisense Oligonucleotide Targeting CAG Repeats: A Patient-Customized Therapy Study for Huntington's Disease.

Sergio Adrian Ocampo-Ortega et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.